BUZZ-Merck falls on downbeat 2026 profit and sales forecasts ** Shares of drugmaker Merck MRK.N fall 2% to $113.11 premarket
** Co says 2026 revenue will be $65.5 bln–$67 bln, with the high end below analysts’ $67.6 bln forecast and profit also came in below Wall Street estimates
** Co reports Q4 adj.profit of $2.04/shr vs analysts' average estimate of $2.01/shr - LSEG data
** Co's quarterly revenue of $16.4 billion beats analysts' average expectation of $16.19 billion
** Shares up ~6% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments